Literature DB >> 9670828

Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.

A N Husain1, N H Siddiqui, J T Stocker.   

Abstract

To define the pathology of bronchopulmonary dysplasia (BPD) in surfactant-treated patients (S-BPD), we reviewed 22 BPD patients (14 S-BPD and eight non-surfactant-treated [NS-BPD]) and 15 age-matched controls, the lungs from which had been processed after formalin inflation. These were studied for surfactant therapy, postconceptional age, crown-rump length, weight at autopsy, radial alveolar count (RAC), mean linear intercept (MLI), RAC/MLI ratio, and amount and extent of fibrosis. On trichrome staining, there was no alveolar septal fibrosis in the control group, whereas there was mild to moderate alveolar septal fibrosis in 5 of 14 S-BPD patients, of which three had fibrosis in most or all of the acini. In contrast, seven of eight NS-BPD had moderate to severe alveolar septal fibrosis in scattered acini throughout the lung. The patients were divided into two groups, with the first group having a postconceptional age at the time of death of up to 40 weeks' gestation. In group 1, the RAC in S-BPD (nine patients) was significantly lower than that of the controls (seven patients); mean, 4.14 and 5.13, respectively (P = .016), whereas the RAC in the NS-BPD (four patients) and the MLI in both S-BPD and NS-BPD were not statistically significantly different. In group 2, those with adjusted age greater than term, the mean RAC, a measure of acinar complexity, was 3.89 in the S-BPD (five patients) and 3.90 in the NS-BPD (four patients), whereas in the control group (eight patients), it was 5.79 (P = .0007). The mean MLI, a measure of alveolar size, was 0.21 and 0.17 in the S-BPD and NS-BPD groups, respectively, each of which was significantly greater than the mean value of 0.12 in the control group (P = .0003). The comparison of RAC/MLI ratios showed similar statistically significant differences. Based on these results, we conclude that (1) the amount of alveolar septal fibrosis is substantially less and tends to be more diffuse in S-BPD than in NS-BPD; (2) during the period after birth, there is a partial to complete arrest in acinar development (alveolar saccular and alveolar) of similar severity for S-BPD and NS-BPD; and (3) even though on histological examination there are minimal changes, RAC, MLI, and their ratio may be used to support the diagnosis of BPD and help in assessing the amount of lung damage that occurs in S-BPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9670828     DOI: 10.1016/s0046-8177(98)90280-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  180 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Monitoring cardiovascular function in infants with chronic lung disease of prematurity.

Authors:  S H Abman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

3.  Increased Cardiac Output and Preserved Gas Exchange Despite Decreased Alveolar Surface Area in Rats Exposed to Neonatal Hyperoxia and Adult Hypoxia.

Authors:  Kara N Goss; Robert S Tepper; Tim Lahm; Shawn K Ahlfeld
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

4.  Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice.

Authors:  Binoy Shivanna; Shaojie Zhang; Ananddeep Patel; Weiwu Jiang; Lihua Wang; Stephen E Welty; Bhagavatula Moorthy
Journal:  Toxicol Sci       Date:  2015-08-13       Impact factor: 4.849

Review 5.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

6.  Very prematurely born infants wheezing at follow-up: lung function and risk factors.

Authors:  Simon Broughton; Mark R Thomas; Louise Marston; Sandra A Calvert; Neil Marlow; Janet L Peacock; Gerrard F Rafferty; Anne Greenough
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

7.  Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice.

Authors:  Vivek Balasubramaniam; Sharon L Ryan; Gregory J Seedorf; Emily V Roth; Thatcher R Heumann; Mervin C Yoder; David A Ingram; Christopher J Hogan; Neil E Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-11       Impact factor: 5.464

8.  Catch-up alveolarization in ex-preterm children: evidence from (3)He magnetic resonance.

Authors:  Manjith Narayanan; Caroline S Beardsmore; John Owers-Bradley; Cristian M Dogaru; Marius Mada; Iain Ball; Ruslan R Garipov; Claudia E Kuehni; Ben D Spycher; Michael Silverman
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

Review 9.  Ureaplasma and BPD.

Authors:  Suhas G Kallapur; Boris W Kramer; Alan H Jobe
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 10.  Progress in understanding the pathogenesis of BPD using the baboon and sheep models.

Authors:  Kurt H Albertine
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.